Sfoglia per Autore
Molecular and cytogenetic characterization of a new case of t(5;17)(q35;q21) variant acute promyelocytic leukemia
2005-01-01 NICCI C; OTTAVIANI E; LUATTI S; GRAFONE T; TONELLI M; MOTTA MR; MALAGOLA M; MARZOCCHI G; MARTINELLI G; BACCARANI M; TESTONI N.
Presence or the Emergence of a F317L BCR-ABL Mutation May Be Associated With Resistance to Dasatinib in Philadelphia Chromosome Positive Leukemia
2006-01-01 S. Soverini;G. Martinelli;S. Colarossi;A. Gnani;F. Castagnetti;G. Rosti;C. Bosi;S. Paolini;M. Rondoni;P. P. Piccaluga;F. Palandri;P. Giannoulia;G. Marzocchi;S. Luatti;N. Testoni;I. Iacobucci;D. Cilloni;G. Saglio;M. Baccarani
Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection.
2006-01-01 Lemoli R; Catani L; Talarico S; Loggi E; Gramenzi A; Baccarani U; Fogli M; Grazi G; Aluigi M; Marzocchi G; Bernardi M; Pinna A; Bresadola F; Baccarani M; Andreone P.
Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain
2007-01-01 Soverini S; Colarossi S; Gnani A; Castagnetti F; Rosti G; Bosi C; Paolini S; Rondoni M; Piccaluga PP; Palandri F; Giannoulia P; Marzocchi G; Luatti S; Testoni N; Iacobucci I; Cilloni D; Saglio G; Baccarani M; Martinelli G.
Increased donor CD86+CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease.
2008-01-01 Arpinati M; Chirumbolo G; Marzocchi G; Baccarani M; Rondelli D.
Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up
2008-01-01 Palandri F, Castagnetti F, Testoni N, Luatti S, Marzocchi G, Bassi S, Breccia M, Alimena G, Pungolino E, Rege-Cambrin G, Varaldo R, Miglino M, Specchia G, Zuffa E, Ferrara F, Bocchia M, Saglio G, Pane F, Alberti D, Martinelli G, Baccarani M, Rosti G; GIMEMA Working Party on Chronic Myeloid Leukemia
Acute promyelocytic leukemia with amplification of PML-RARalpha rearrangement:clinical implications
2008-01-01 Luatti S.; Marzocchi G.; Ottaviani E.; Baldazzi C.; Stacchini M.; Gamberini C.; Salmi F.; Martinelli G.; Baccarani M.; Testoni N.
Influence of additional cytogenetic abnormalities on the response and survival in late chronic phase chronic myeloid leukemia patients treated with imatinib: long-term results.
2009-01-01 Palandri F; Testoni N; Luatti S; Marzocchi G; Baldazzi C; Stacchini M; Castagnetti F; Breccia M; Specchia G; Pane F; Saglio G; Martinelli G; Baccarani M; Rosti G.
Emergence of clonal chromosomal abnormalities in Philadelphia negative hematopoiesis in chronic myeloid leukemia patients treated with nilotinib after failure of imatinib therapy
2009-01-01 Baldazzi C; Luatti S; Marzocchi G; Stacchini M; Gamberini C; Castagnetti F; Palandri F; Rosti G; Baccarani M; Testoni N.
Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response, a study of the GIMEMA CML WP.
2009-01-01 Testoni N; Marzocchi G; Luatti S; Amabile M; Baldazzi C; Stacchini M; Nanni M; Rege-Cambrin G; Giugliano E; Giussani U; Abruzzese E; Kerim S; Grimoldi MG; Gozzetti A; Crescenzi B; Carcassi C; Bernasconi P; Cuneo A; Albano F; Fugazza G; Zaccaria A; Martinelli G; Pane F; Rosti G; Baccarani M.
Deletionsof the derivative chromosome 9 do not influence the response and the outcomeof chronic myeloid leukemia in early chronic phase treated with imatinibmesylate: GIMEMA CML Working Party analysis
2010-01-01 Castagnetti F; Testoni N;Luatti S; Marzocchi G; Mancini M; Kerim S; Giugliano E; Albano F; Cuneo A;Abruzzese E; Martino B; Palandri F; Amabile M; Iacobucci I; Alimena G; Pane F; Martinelli G; Saglio G; Baccarani M; Rosti G
B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene.
2010-01-01 Baldazzi C; Iacobucci I; Luatti S; Ottaviani E; Marzocchi G; Paolini S; Stacchini M; Papayannidis C; Gamberini C; Martinelli G; Baccarani M; Testoni N.
Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenetic and prognostic implications.
2010-01-01 Zaccaria A; Testoni N; Valenti AM; Luatti S; Tonelli M; Marzocchi G; Cipriani R; Baldazzi C; Giannini B; Stacchini M; Gamberini C; Castagnetti F; Rosti G; Azzena A; Cavazzini F; Cianciulli AM; Dalsass A; Donti E; Giugliano E; Gozzetti A; Grimoldi MG; Ronconi S; Santoro A; Spedicato F; Zanatta L; Baccarani M
CLINICAL OUTCOMES PREDICTION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH THALIDOMIDE-DEXAMETHASONE AND AUTOLOGOUS STEM CELL TRANSPLANTATION BY 8-GENE SIGNATURE OF CD138+ PLASMA CELLS
2010-01-01 Terragna C.; Remondini D.; Martinelli G.; Tosi P.; Zamagni E.; Tacchetti P.; Perrone G.; Brioli A.; Ceccolini M.; Testoni N.; Marzocchi G.; Castellani G.; Durante S.; Di Raimondo F.; Patriarca F.; Catalano L.; Masini L.; Ledda A.; Angelucci E.; Galieni P.; Gozzetti A.; Baccarani M.; Cavo M.
Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis.
2011-01-01 Marzocchi G.; Castagnetti F.; Luatti S.; Baldazzi C.; Stacchini M.; Gugliotta G.; Amabile M.; Specchia G.; Sessarego M.; Giussani U.; Valori L.; Discepoli G.; Montaldi A.; Santoro A.; Bonaldi L.; Giudici G.; Cianciulli A.M.; Giacobbi F.; Palandri F.; Pane F.; Saglio G.; Martinelli G.; Baccarani M.; Rosti G.; Testoni N.
Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party.
2011-01-01 Gugliotta G.; Castagnetti F.; Palandri F.; Breccia M.; Intermesoli T.; Capucci A.; Martino B.; Pregno P.; Rupoli S.; Ferrero D.; Gherlinzoni F.; Montefusco E.; Bocchia M.; Tiribelli M.; Pierri I.; Grifoni F.; Marzocchi G.; Amabile M.; Testoni N.; Martinelli G.; Alimena G.; Pane F.; Saglio G.; Baccarani M.; Rosti G.
Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis
2012-01-01 S Luatti; F Castagnetti; G Marzocchi; C Baldazzi; G Gugliotta; I Iacobucci; G Specchia; L Zanatta; G Rege-Cambrin; M Mancini; E Abruzzese; A Zaccaria; M G Grimoldi; A Gozzetti; G Ameli; M A Capucci; G Palka; P Bernasconi; F Palandri; F Pane; G Saglio; G Martinelli; G Rosti; M Baccarani; N Testoni; on behalf of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Working Party on CML
High CNA level and over-expression of genes involved in response mechanisms to genotoxic stress characterize newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted TP53
2012-01-01 Terragna C; Martello M; Pantani L; Patriarca F; Zamagni E; Galli M; Tacchetti P; Petrucci MT; Crippa C; Bringhen S; Brioli A; Offidani M; Perrone G; Zannetti BA; Borsi E; Testoni N; Marzocchi G; Baccarani M; Martinelli G; Cavo M.
Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide–dexamethasone incorporated into double autologous transplantation
2013-01-01 Carolina Terragna;Matteo Renzulli;Daniel Remondini;Enrico Tagliafico;Francesco Di Raimondo;Francesca Patriarca;Giovanni Martinelli;Enrica Roncaglia;Luciano Masini;Patrizia Tosi;Elena Zamagni;Paola Tacchetti;Antonio Ledda;Annamaria Brioli;Emanuele Angelucci;Nicoletta Testoni;Giulia Marzocchi;Piero Galieni;Alessandro Gozzetti;Marina Martello;Flores Dico;Katia Mancuso;Michele Cavo
Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma.
2014-01-01 Zamagni, E; Nanni, C; Tacchetti, P; Pantani, L; Marzocchi, G; Zannetti, B; Terragna, C; Mancuso, K; Rocchi, S; Pezzi, A; Testoni, N; Fanti, S; Cavo, M.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Molecular and cytogenetic characterization of a new case of t(5;17)(q35;q21) variant acute promyelocytic leukemia | NICCI C; OTTAVIANI E; LUATTI S; GRAFONE T; TONELLI M; MOTTA MR; MALAGOLA M; MARZOCCHI G; MARTINELLI G; BACCARANI M; TESTONI N. | 2005-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Presence or the Emergence of a F317L BCR-ABL Mutation May Be Associated With Resistance to Dasatinib in Philadelphia Chromosome Positive Leukemia | S. Soverini;G. Martinelli;S. Colarossi;A. Gnani;F. Castagnetti;G. Rosti;C. Bosi;S. Paolini;M. Rondoni;P. P. Piccaluga;F. Palandri;P. Giannoulia;G. Marzocchi;S. Luatti;N. Testoni;I. Iacobucci;D. Cilloni;G. Saglio;M. Baccarani | 2006-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection. | Lemoli R; Catani L; Talarico S; Loggi E; Gramenzi A; Baccarani U; Fogli M; Grazi G; Aluigi M; Marzocchi G; Bernardi M; Pinna A; Bresadola F; Baccarani M; Andreone P. | 2006-01-01 | STEM CELLS | - | 1.01 Articolo in rivista | - |
| Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain | Soverini S; Colarossi S; Gnani A; Castagnetti F; Rosti G; Bosi C; Paolini S; Rondoni M; Piccaluga PP; Palandri F; Giannoulia P; Marzocchi G; Luatti S; Testoni N; Iacobucci I; Cilloni D; Saglio G; Baccarani M; Martinelli G. | 2007-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Increased donor CD86+CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease. | Arpinati M; Chirumbolo G; Marzocchi G; Baccarani M; Rondelli D. | 2008-01-01 | TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up | Palandri F, Castagnetti F, Testoni N, Luatti S, Marzocchi G, Bassi S, Breccia M, Alimena G, Pungolino E, Rege-Cambrin G, Varaldo R, Miglino M, Specchia G, Zuffa E, Ferrara F, Bocchia M, Saglio G, Pane F, Alberti D, Martinelli G, Baccarani M, Rosti G; GIMEMA Working Party on Chronic Myeloid Leukemia | 2008-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Acute promyelocytic leukemia with amplification of PML-RARalpha rearrangement:clinical implications | Luatti S.; Marzocchi G.; Ottaviani E.; Baldazzi C.; Stacchini M.; Gamberini C.; Salmi F.; Martinelli G.; Baccarani M.; Testoni N. | 2008-01-01 | LEUKEMIA RESEARCH | - | 1.01 Articolo in rivista | - |
| Influence of additional cytogenetic abnormalities on the response and survival in late chronic phase chronic myeloid leukemia patients treated with imatinib: long-term results. | Palandri F; Testoni N; Luatti S; Marzocchi G; Baldazzi C; Stacchini M; Castagnetti F; Breccia M; Specchia G; Pane F; Saglio G; Martinelli G; Baccarani M; Rosti G. | 2009-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Emergence of clonal chromosomal abnormalities in Philadelphia negative hematopoiesis in chronic myeloid leukemia patients treated with nilotinib after failure of imatinib therapy | Baldazzi C; Luatti S; Marzocchi G; Stacchini M; Gamberini C; Castagnetti F; Palandri F; Rosti G; Baccarani M; Testoni N. | 2009-01-01 | LEUKEMIA RESEARCH | - | 1.01 Articolo in rivista | - |
| Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response, a study of the GIMEMA CML WP. | Testoni N; Marzocchi G; Luatti S; Amabile M; Baldazzi C; Stacchini M; Nanni M; Rege-Cambrin G; Giugliano E; Giussani U; Abruzzese E; Kerim S; Grimoldi MG; Gozzetti A; Crescenzi B; Carcassi C; Bernasconi P; Cuneo A; Albano F; Fugazza G; Zaccaria A; Martinelli G; Pane F; Rosti G; Baccarani M. | 2009-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Deletionsof the derivative chromosome 9 do not influence the response and the outcomeof chronic myeloid leukemia in early chronic phase treated with imatinibmesylate: GIMEMA CML Working Party analysis | Castagnetti F; Testoni N;Luatti S; Marzocchi G; Mancini M; Kerim S; Giugliano E; Albano F; Cuneo A;Abruzzese E; Martino B; Palandri F; Amabile M; Iacobucci I; Alimena G; Pane F; Martinelli G; Saglio G; Baccarani M; Rosti G | 2010-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene. | Baldazzi C; Iacobucci I; Luatti S; Ottaviani E; Marzocchi G; Paolini S; Stacchini M; Papayannidis C; Gamberini C; Martinelli G; Baccarani M; Testoni N. | 2010-01-01 | LEUKEMIA RESEARCH | - | 1.01 Articolo in rivista | - |
| Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenetic and prognostic implications. | Zaccaria A; Testoni N; Valenti AM; Luatti S; Tonelli M; Marzocchi G; Cipriani R; Baldazzi C; Giannini B; Stacchini M; Gamberini C; Castagnetti F; Rosti G; Azzena A; Cavazzini F; Cianciulli AM; Dalsass A; Donti E; Giugliano E; Gozzetti A; Grimoldi MG; Ronconi S; Santoro A; Spedicato F; Zanatta L; Baccarani M | 2010-01-01 | CANCER GENETICS AND CYTOGENETICS | - | 1.01 Articolo in rivista | - |
| CLINICAL OUTCOMES PREDICTION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH THALIDOMIDE-DEXAMETHASONE AND AUTOLOGOUS STEM CELL TRANSPLANTATION BY 8-GENE SIGNATURE OF CD138+ PLASMA CELLS | Terragna C.; Remondini D.; Martinelli G.; Tosi P.; Zamagni E.; Tacchetti P.; Perrone G.; Brioli A.; Ceccolini M.; Testoni N.; Marzocchi G.; Castellani G.; Durante S.; Di Raimondo F.; Patriarca F.; Catalano L.; Masini L.; Ledda A.; Angelucci E.; Galieni P.; Gozzetti A.; Baccarani M.; Cavo M. | 2010-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis. | Marzocchi G.; Castagnetti F.; Luatti S.; Baldazzi C.; Stacchini M.; Gugliotta G.; Amabile M.; Specchia G.; Sessarego M.; Giussani U.; Valori L.; Discepoli G.; Montaldi A.; Santoro A.; Bonaldi L.; Giudici G.; Cianciulli A.M.; Giacobbi F.; Palandri F.; Pane F.; Saglio G.; Martinelli G.; Baccarani M.; Rosti G.; Testoni N. | 2011-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party. | Gugliotta G.; Castagnetti F.; Palandri F.; Breccia M.; Intermesoli T.; Capucci A.; Martino B.; Pregno P.; Rupoli S.; Ferrero D.; Gherlinzoni F.; Montefusco E.; Bocchia M.; Tiribelli M.; Pierri I.; Grifoni F.; Marzocchi G.; Amabile M.; Testoni N.; Martinelli G.; Alimena G.; Pane F.; Saglio G.; Baccarani M.; Rosti G. | 2011-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis | S Luatti; F Castagnetti; G Marzocchi; C Baldazzi; G Gugliotta; I Iacobucci; G Specchia; L Zanatta; G Rege-Cambrin; M Mancini; E Abruzzese; A Zaccaria; M G Grimoldi; A Gozzetti; G Ameli; M A Capucci; G Palka; P Bernasconi; F Palandri; F Pane; G Saglio; G Martinelli; G Rosti; M Baccarani; N Testoni; on behalf of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Working Party on CML | 2012-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| High CNA level and over-expression of genes involved in response mechanisms to genotoxic stress characterize newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted TP53 | Terragna C; Martello M; Pantani L; Patriarca F; Zamagni E; Galli M; Tacchetti P; Petrucci MT; Crippa C; Bringhen S; Brioli A; Offidani M; Perrone G; Zannetti BA; Borsi E; Testoni N; Marzocchi G; Baccarani M; Martinelli G; Cavo M. | 2012-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide–dexamethasone incorporated into double autologous transplantation | Carolina Terragna;Matteo Renzulli;Daniel Remondini;Enrico Tagliafico;Francesco Di Raimondo;Francesca Patriarca;Giovanni Martinelli;Enrica Roncaglia;Luciano Masini;Patrizia Tosi;Elena Zamagni;Paola Tacchetti;Antonio Ledda;Annamaria Brioli;Emanuele Angelucci;Nicoletta Testoni;Giulia Marzocchi;Piero Galieni;Alessandro Gozzetti;Marina Martello;Flores Dico;Katia Mancuso;Michele Cavo | 2013-01-01 | ANNALS OF HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma. | Zamagni, E; Nanni, C; Tacchetti, P; Pantani, L; Marzocchi, G; Zannetti, B; Terragna, C; Mancuso, K; Rocchi, S; Pezzi, A; Testoni, N; Fanti, S; Cavo, M. | 2014-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile